Transdermal Medication Patches (Adhesive Chemicals, Fentanyl Patch Disposal, Child Access Risk) — household safety profile
Moderate riskTransdermal patches deliver medication through skin over 1-7 days: fentanyl (pain), nicotine (smoking cessation), estradiol (HRT), lidocaine (pain), scopolamine (nausea).
What is this product?
Transdermal patches deliver medication through skin over 1-7 days: fentanyl (pain), nicotine (smoking cessation), estradiol (HRT), lidocaine (pain), scopolamine (nausea). Chemical concerns: adhesive (acrylate or silicone-based — contact dermatitis in 10-15% of users), penetration enhancers (oleic acid, propylene glycol, DMSO), and residual drug in used patches. Fentanyl patch disposal: used patches retain 28-84% of original fentanyl dose — lethal to children if accessed. FDA REMS (Risk Evaluation and Mitigation Strategy): fentanyl patches must include disposal instructions (fold adhesive sides together, flush or use drug take-back). Accidental pediatric fentanyl patch exposure: FDA reports 26 deaths (1997-2018).
What's in it
Click any compound name for its full safety profile, regulatory consensus, and exposure data.
Adhesive Component
Frequently asked questions
No FAQs generated.
Look up Transdermal Medication Patches (Adhesive Chemicals, Fentanyl Patch Disposal, Child Access Risk) in the home app
Search by ingredient, browse by category, or compare to alternatives in the live app.
Open in home View raw API dataReference data, not professional advice. Aggregates publicly available regulatory and scientific information. Why we built ALETHEIA →